Meningitis shot that fights five different strains shows promise in latest trial
According to the World Health Organization, meningitis caused an estimated 25,000 deaths in 2019. European Centre for Disease Prevention and Control A phase 3 trial found that a new meningococcal disease vaccine is safe and effective and also induces a strong immune response across five strains of meningococcal bacteria. The results were published May 24 in the New England Journal of Medicine. The vaccine could be a useful tool in eliminating meningitis in African countries including parts of Senegal, Mali, and Ethiopia. [Related: A once-forgotten antibiotic could be a new weapon against drug-resistant infections.] Meningococcal disease is a cause of meningitis and blood poisoning. According to the World Health Organization, meningitis caused an estimated 25,000 deaths in 2019. While vaccines are readily available in wealthier countries, vaccinating the more vulnerable regions has been...